{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:18:56Z","timestamp":1772165936255,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01962-w","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:48:10Z","timestamp":1761655690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The utility of radiopharmaceutical uptake in the bladder neck and prostate on preoperative FDG PET\/CT in determining urethral surgical margin positivity in patients undergoing radical cystoprostatectomy for bladder cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Resat","family":"Ayd\u0131n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rifat Burak","family":"Erg\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An\u0131l","family":"Tantekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"Sanl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selcuk","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Oner","family":"Sanl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faruk","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"3","key":"1962_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1586\/14737140.7.3.383","volume":"7","author":"F Liedberg","year":"2014","unstructured":"Liedberg F, Chebil G, M\u00e5nsson W. Urothelial carcinoma in the prostatic urethra and prostate: current controversies. Expert Rev Anticancer Ther. 2014;7(3):383\u201390.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"1962_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.juro.2008.03.037","volume":"180","author":"W Kassouf","year":"2008","unstructured":"Kassouf W, Spiess PE, Brown GA, Liu P, Grossman HB, Dinney CP, et al. Prostatic urethral biopsy has limited usefulness in counseling patients regarding final urethral margin status during orthotopic neobladder reconstruction. J Urol. 2008;180(1):164\u20137.","journal-title":"J Urol"},{"issue":"6","key":"1962_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/2051415815617876","volume":"9","author":"F-C von Rundstedt","year":"2016","unstructured":"von Rundstedt F-C, Mata DA, Shen S, Li Y, Godoy G, Lerner SP. Transurethral biopsy of the prostatic urethra is associated with final apical margin status at radical cystoprostatectomy. J Clin Urol. 2016;9(6):404\u20138.","journal-title":"J Clin Urol"},{"key":"1962_CR4","doi-asserted-by":"crossref","unstructured":"Kates M, Ball MW, Chappidi MR, Baras AS, Gordetsky J, Sopko NA, Brant A, Pierorazio PM, Epstein JI, Schoenberg MP. Accuracy of urethral frozen section during radical cystectomy for bladder cancer. In: Urologic Oncology: Seminars and Original Investigations: 2016: Elsevier; 2016;532:e531-532. e536.","DOI":"10.1016\/j.urolonc.2016.06.014"},{"issue":"5","key":"1962_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/MOU.0000000000000798","volume":"30","author":"SMH Einerhand","year":"2020","unstructured":"Einerhand SMH, van Gennep EJ, Mertens LS, Hendricksen K, Donswijk ML, van der Poel HG, et al. 18F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography in muscle-invasive bladder cancer. Curr Opin Urol. 2020;30(5):654\u201364.","journal-title":"Curr Opin Urol"},{"issue":"8","key":"1962_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.1464-410X.2009.08558.x","volume":"104","author":"DA Barocas","year":"2009","unstructured":"Barocas DA, Patel SG, Chang SS, Clark PE, Smith JA Jr, Cookson MS. Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology. BJU Int. 2009;104(8):1091\u20137.","journal-title":"BJU Int"},{"issue":"4","key":"1962_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.eururo.2007.06.045","volume":"53","author":"J Huguet","year":"2008","unstructured":"Huguet J, Monllau V, Sabat\u00e9 S, Rodriguez-Faba O, Algaba F, Palou J, et al. Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients. Eur Urol. 2008;53(4):785\u201393.","journal-title":"Eur Urol"},{"issue":"5","key":"1962_CR8","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.juro.2013.05.034","volume":"190","author":"HM Bruins","year":"2013","unstructured":"Bruins HM, Djaladat H, Ahmadi H, Sherrod A, Cai J, Miranda G, et al. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens. J Urol. 2013;190(5):1704\u20139.","journal-title":"J Urol"},{"key":"1962_CR9","doi-asserted-by":"crossref","unstructured":"Bizzarri FP, Nelson AW, Colquhoun AJ, Lobo N. Utility of fluorodeoxyglucose positron emission tomography\/computed tomography in detecting lymph node involvement in comparison to conventional imaging in patients with bladder cancer with variant histology. Eur Urol Oncol. 2025; S2588-9311(25)00097-5. Online ahead of print.","DOI":"10.1016\/j.euo.2025.03.019"},{"issue":"1","key":"1962_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.juro.2008.03.037","volume":"180","author":"W Kassouf","year":"2008","unstructured":"Kassouf W, Spiess PE, Brown GA, Liu P, Grossman HB, Dinney CP, Kamat AM. Prostatic urethral biopsy has limited usefulness in counseling patients regarding final urethral margin status during orthotopic neobladder reconstruction. J Urol. 2008;180(1):164\u20137. discussion 167.","journal-title":"J Urol"},{"issue":"1","key":"1962_CR11","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1097\/RLU.0000000000000398","volume":"40","author":"S Chondrogiannis","year":"2015","unstructured":"Chondrogiannis S, Marzola MC, Colletti PM, Rubello D. Proposal of a new acquisition protocol for bladder cancer visualization with 18F-FDG PET\/CT. Clin Nucl Med. 2015;40(1):e78-80.","journal-title":"Clin Nucl Med"},{"key":"1962_CR12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s00259-012-2294-6","volume":"40","author":"B Nayak","year":"2013","unstructured":"Nayak B, Dogra PN, Naswa N, Kumar R. Diuretic 18 f-fdg pet\/ct imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique. Eur J Nucl Med Mol Imaging. 2013;40:386\u201393.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10231","key":"1962_CR13","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395(10231):1208\u201316.","journal-title":"Lancet"},{"issue":"6","key":"1962_CR14","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","volume":"5","author":"WP Fendler","year":"2019","unstructured":"Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, et al. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial. JAMA Oncol. 2019;5(6):856\u201363.","journal-title":"JAMA Oncol"},{"issue":"Suppl 1","key":"1962_CR15","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1007\/s00259-013-2361-7","volume":"40","author":"H Jadvar","year":"2013","unstructured":"Jadvar H. Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET\/CT: utility and limitations. Eur J Nucl Med Mol Imaging. 2013;40(Suppl 1):S5\u201310.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01962-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01962-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01962-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:06:09Z","timestamp":1761696369000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01962-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1962"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01962-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6580219\/v1","asserted-by":"object"}]},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of Istanbul University (Protocol code: E-29624016\u2013050.99-1810738). All procedures were conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. The need for informed consent was waived due to the retrospective nature of the study and in accordance with national regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":".","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"The datasets generated and\/or analysed during the current study are available in the Zenodo repository at"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}],"article-number":"271"}}